EPH63 Exploring the Potential Public Health Benefits of a Respiratory Syncytial Virus (RSV) Vaccine Candidate (Ad26.RSV.preF/RSV) Among Individuals Aged 65 Years and Older in the UK: A Preliminary Mathematical Modelling Approach

Autor: Shiri, T, Cox, A, Lied Lied, A, Puggina, A, Chapman, R, Lozowicki, P, Duan, C, Hernandez-Pastor, L, Van Effelterre, T, Postma, MJ
Zdroj: In Value in Health December 2022 25(12) Supplement:S203-S203
Databáze: ScienceDirect
Externí odkaz: